Medical Marijuana Practice Group
With the passing of Medical Marijuana Act on April 17, 2016, the Commonwealth of Pennsylvania has entered a new era of therapy and treatment for patients suffering from Serious Medical Conditions enumerated in the Act such as Cancer, Parkinson’s Disease, chronic pain not treatable by conventional pain therapies, seizures, Epilepsy, Autism and Neuropathies. We at Capozzi Adler, PC support this courageous and compassionate legislation and are proud to announce the services of our Cannabis Practice Group. We are uniquely prepared, based on our experience in serving Health Care Providers and navigating the complex statutory and regulatory issues that will come with Department of Health oversight and administration of the Pennsylvania Medical Marijuana Program, to assist potential grower/processors and dispensaries in obtaining licenses/permits and ongoing Compliance with the Act and future regulations. Our Firm will also bring a team approach integrating our other practice areas in all aspects of the Medical Marijuana business including:
- Labor and Employment issues
- Business Organization
- Regulatory compliance and external auditing
- Enforcement Issues
With the passing of the Medical Marijuana Act, Pennsylvania joined 23 other states in legalizing medical marijuana, however it is still a federal crime to grow, sell and/or use marijuana as it remains a Schedule I controlled substance under applicable federal law. All content herein is not intended to provide legal advice to assist with violation of any state or federal law.
The members of this practice group are Daniel K. Natirboff, Esquire, Glenn A. Parno, Esquire, Bruce G. Baron, Esquire and Brandon S. Williams, Esquire.